sglt2 inhibitors vs glp 1 agonists and GLP-1 receptor agonists: a sound combination GLP-1 Agonists vs. SGLT2 Inhibitors:
Description
doi: 10.1177/20420188231222367 11 MadsenMSAHolmJBPallejAWismannPFabriciusKRigboltKet al

A study that investigated the effects of insulin and GLP-1RAs (exenatide and dulaglutide) on BMD over a 52-week duration gathered 70 individuals with type 2 diabetes

They expect some weight regain

Biol Psychiatry (2020) 87(9):797807
